Discovery chemistry, Immunology, Immuno-oncology & Neuroscience, Analytical services, Process R&D, GMP manufacturing
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
161
NCT04859244
First-in-Human Study of Orally Administered GS-441524 for COVID-19
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 1, 2021
Completion: Aug 1, 2021
NCT02928094
Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia
Phase: Phase 3
Role: Collaborator
Start: Jan 1, 2023
Completion: Dec 31, 2024
Loading map...